Acquired
Novo Nordisk (Ozempic)
David Rosenthal
There is room for everybody here. And the barriers to entry from everything we talked about to competing in this area are very, very high. So like there will be a number of competitors, including Eli Lilly, but there will be plenty of demand and profits for everyone. Yeah. That's the bull case.
0
💬
0
Comments
Log in to comment.
There are no comments yet.